# Kathryn J. Lucas, M.D. – FDA 483, Apr 8, 2016

Source: https://www.keypedia.com/records/483/kathryn-j-lucas-md/3342248a-b708-4835-a143-4f8503805302

> FDA 483 for Kathryn J. Lucas, M.D. on April 08, 2016. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kathryn J. Lucas, M.D.
- Inspection Date: 2016-04-08
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Kathryn J. Lucas, M.D. in Morehead City, NC, identified a significant deviation from the investigational plan for a Type 1 diabetes study. The firm enrolled subjects who did not meet the protocol's eligibility criteria regarding their diabetes diagnosis type and prior medication use. This failure to adhere to the study protocol raises concerns about the integrity of the clinical trial data.

## Related Documents

- [483 - 2022-12-13](https://www.keypedia.com/records/483/kathryn-j-lucas-md/efde7e88-fdf3-4a3c-91c8-f31374a97eaa) — date: December 13, 2022
- [EIR - 2018-08-27](https://www.keypedia.com/records/eir/kathryn-j-lucas-md/c8be390e-df23-4fd6-b377-d3eb2e29891f) — date: August 27, 2018
- [483 - 2018-08-27](https://www.keypedia.com/records/483/kathryn-j-lucas-md/b0ab9ff9-a41e-4876-b378-1b96f68aa044) — date: August 27, 2018
- [EIR - 2016-04-08](https://www.keypedia.com/records/eir/kathryn-j-lucas-md/7d077916-1250-4ae7-bf74-03e9de2ebccb) — date: April 8, 2016
- [483 - 2015-05-22](https://www.keypedia.com/records/483/kathryn-j-lucas-md/bfadf4c8-48de-47ee-ac41-fdc563bbcdb5) — date: May 22, 2015

## Related Officers

- [Cynthia Kleppinger](https://www.keypedia.com/people/cynthia-kleppinger/8badb3bc-141f-4094-a02b-b572fdb68fbf)
- [issuing_officer](https://www.keypedia.com/people/nicole-m-bell/56a038c4-9323-43ac-93d7-0b6911286b73)

Company: https://www.keypedia.com/companies/kathryn-j-lucas-md/68d4e935-e6f8-40bb-8342-e21633c452f9

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7